6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01730950 [Disease Site] Glioblastoma [Description] 
Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description